Patent · US Active

Oxaborole esters and uses thereof

US10562921B2 · kind B2 · utility

1Cited by
4References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 9, 2017
Grant dateFeb 18, 2020
Priority date
Expiry dateMay 9, 2037

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides oxaborole ester compounds and compositions thereof which are useful to treat diseases associated with parasites, such as Chagas Disease and African Animal Trypanosomosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.